肤阴洁品牌怎么样 申请店铺

我要投票 肤阴洁在女性洗液行业中的票数:211 更新时间:2025-04-04
肤阴洁是哪个国家的品牌?「肤阴洁」是 广西源安堂药业有限公司 旗下著名品牌。该品牌发源于广西贵港市,由创始人莫董在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力肤阴洁品牌出海!通过在本页面挂载肤阴洁品牌的产品链接和联系邮箱,可以提高肤阴洁产品曝光!跨境电商爆单神器,目前只要100元/年哦~

肤阴洁怎么样

具有独立自主知识产权,涵盖OTC/医院/超市等市场板块的诸多产品,集科研/生产/销售/服务于一体的大型中药制药企业


广西源安堂药业有限公司是一个集科研、生产、销售、服务于一体、拥有超亿元固定资产、年生产能力超10亿元规模的广西民族品牌特色药生产企业。

公司行政总部、现代化药品生产基地坐落于广西桂平市中沙镇,公司营销中心及技术研发机构设立在广西首府南宁市。公司现有员工600余人,其中,包括硕士研究生、本科生、大中专生等各类专业技术人才约300余人。

公司成立30年来,结合自身的技术资源和品牌优势,成功研发生产出一系列具有独立自主知识产权的国家新药,投放市场后,产销两旺,丰富了广西民族特色药品的阵营,带来了巨大的社会经济效益。公司主要国药有:肤阴洁®复方黄松洗液、肤阴洁®复方黄松湿巾、源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊等。公司研发生产的几类国药,都是取源于桂东南地道的原生态中药材,精心萃取,科学配伍,各有特色。

经过30多年的锤炼与洗礼,公司各类国药产品,形成了具有“原生态科技创新型”和“市场化品牌实用型”的特点。

肤阴洁®复方黄松洗液和湿巾是公司的支柱产品,自成系列,形成并丰富了涵盖OTC药店销售、医院销售、连锁销售等市场营销体系,在全国近30个省、直辖市、自治区构建起了布局合理的市场营销网络。

源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊是广西乃至全国仅有的民族特色药,显示出独特的疗效。源安堂®银胡感冒散,是以青蒿素为主要成分的创新型国药,广泛应用于小孩、中老年人,其在感冒初期治疗中,成为不打针、不吃药、贴肚脐疗法、治感冒的典范,获得国家发明专利,荣获“世界卫生组织教科文卫部科技发明特别贡献奖”,是广西中成药富有民族特色的药品,在华东、华中、华南市场销售中保持旺盛的势头。源安堂®肠胃散、朱虎化瘀酊等国药产品,在临床实践中各具特色,疗效显著,销售发展潜力很大,具有无限的医药商机和市场价值。

公司发展30多年来,坚持走科技创新、品牌强业的发展道路,努力培育和打造企业核心竞争力,拥有技术发明创造和各项产品商标专利共17项,公司将科技研发成果转化为社会生产力,有利于推动广西社会经济的和谐发展。公司“源安堂”和“肤阴洁”两大品牌的不断推广与发展,为其赋予了丰富的科技内涵和潜在的品牌价值,由于公司国药品牌的影响力、市场销售的增长率和广大消费者的认同感。

广西源安堂药业有限公司将在广西自治区各级党委、政府的正确领导下,在广西食品药品监督管理局和自治区林业厅的精心指导下,结合自身优势,以市场为导向,以研发为动力,以效益为核心,以人为本,苦练内功,加强管理,整合资源,改革创新,励精图治,带动地方经济发展,打造广西民族中药特色品牌,为发展中国中医药和人类健康事业再作贡献。


Guangxi yuanantang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine pharmaceutical enterprise with independent intellectual property rights, covering OTC / hospital / supermarket and other market segments, integrating scientific research / production / sales / service. It is a Guangxi national brand characteristic pharmaceutical manufacturer with fixed assets of more than 100 million yuan and annual production capacity of more than 1 billion yuan 。 The company's administrative headquarters and modern pharmaceutical production base are located in Zhongsha Town, Guiping City, Guangxi Province. The company's marketing center and technical research and development organization are set up in Nanning, the capital city of Guangxi Province. The company has more than 600 employees, including more than 300 professional and technical talents such as master's degree, undergraduate, college and technical secondary school students. In the past 30 years since its establishment, the company has successfully developed and produced a series of national new drugs with independent intellectual property rights in combination with its own technical resources and brand advantages. After being put on the market, the production and marketing of these drugs have flourished, enriching the camp of drugs with national characteristics in Guangxi and bringing huge social and economic benefits. The main Chinese medicines of the company are Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), fuhuangsong (Fuyinjie), yuanantang (Yinhu Ganmao), yuanantang (Changwei), yuanantang (Zhuhu Huayu) tincture, etc. Several kinds of national medicines developed and produced by the company are all original ecological Chinese herbal medicines from the southeast of Guangxi. They are carefully extracted, scientifically combined and have their own characteristics. After more than 30 years of tempering and baptism, all kinds of Chinese medicine products of the company have formed the characteristics of "original ecological technology innovation type" and "market-oriented brand practical type". Fuyinjie ® compound Huangsong lotion and wipes are the pillar products of the company. They have formed and enriched the marketing system covering OTC drugstore sales, hospital sales, chain sales, etc., and established a reasonable marketing network in nearly 30 provinces, municipalities and autonomous regions. Yuanantang Yinhu Ganmao powder, yuanantang Changwei powder and yuanantang Zhuhu Huayu tincture are the only national characteristic drugs in Guangxi and even in China, showing unique curative effect. Yuanantang ® Yinhu Ganmao powder is an innovative national medicine with artemisinin as the main component, which is widely used in children and middle-aged and elderly people. In the early treatment of cold, it has become a model of no injection, no medicine, sticking navel therapy and treating cold. It has won the national invention patent, won the "special contribution award for scientific and technological invention of the Ministry of education, culture and health of the World Health Organization", and is rich in people in Guangxi Traditional Chinese medicine Ethnic medicine has maintained a strong momentum in the marketing of East China, central China and South China. The national medicine products, such as yuanantang ® changweisan and Zhuhu Huayu tincture, have their own characteristics in clinical practice, significant curative effect, great potential for sales and development, and infinite medical business opportunities and market value. Over the past 30 years of development, the company has adhered to the development path of scientific and technological innovation and strong brand industry, made great efforts to cultivate and build the core competitiveness of the enterprise, with a total of 17 technical invention and creation and various product trademark patents. The company has transformed scientific and technological research and development achievements into social productivity, which is conducive to promoting the harmonious development of social economy in Guangxi. The continuous promotion and development of the company's "yuanantang" and "Fuyinjie" brands endow them with rich scientific and technological connotation and potential brand value. Due to the influence of the company's national medicine brand, the growth rate of market sales and the sense of identity of the majority of consumers. Guangxi yuanantang Pharmaceutical Co., Ltd. will, under the correct leadership of the party committees and governments at all levels in Guangxi Autonomous Region, under the careful guidance of Guangxi food and Drug Administration and the Forestry Department of Guangxi Autonomous Region, combine its own advantages, take the market as the guide, research and development as the driving force, benefit as the core, people-oriented, work hard, strengthen management, integrate resources, reform and innovation, and work hard, We will promote the development of local economy, build Guangxi's national brand of traditional Chinese medicine, and make further contributions to the development of traditional Chinese medicine and human health.

本文链接: https://brand.waitui.com/5f02b73e7.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美国2月贸易逆差1227亿美元

美国商务部普查局4月3日发布数据,2月贸易逆差1227亿美元,预估为逆差1235亿美元,前值为逆差1314亿美元。(界面)

2小时前

美股大型科技股盘前普跌,苹果跌超7%

36氪获悉,美股大型科技股盘前普跌,截至发稿,苹果、亚马逊跌超7%,特斯拉、Arm、英伟达跌超6%,Meta跌超5%,谷歌跌超4%,微软、奈飞跌超3%。

2小时前

热门中概股美股盘前普跌,拼多多跌超6%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超6%,京东跌超5%,百度、爱奇艺、阿里巴巴、B站、蔚来跌超3%,理想汽车跌超2%,网易、腾讯音乐、微博跌超1%。

2小时前

高测股份:控股股东张顼拟询价转让4.99%股份

36氪获悉,高测股份公告,公司控股股东张顼计划通过询价转让方式转让27,308,000股,占公司总股本的4.99%,转让原因为自身资金需求。出让方声明所持股份权属清晰,不存在限制或禁止转让情形,且不违反相关减持规定和承诺。本次询价转让的受让方需为具备相应定价能力和风险承受能力的机构投资者。本次询价转让的价格下限不低于发送认购邀请书之日(即2025年4月3日)前20个交易日高测股份股票交易均价的70%。

2小时前

欧盟成员国拟表决对美关税反制措施

欧盟高级官员4月3日表示,欧盟成员国计划9日投票表决针对美方25%钢铝关税的反制措施。欧盟委员会负责贸易和经济安全等事务的委员马罗什·谢夫乔维奇表示,不合理的关税最终只会适得其反,欧盟将以冷静、有步骤且团结一致的方式作出回应。(新华社)

2小时前

本页详细列出关于Primera芙莉美娜的品牌信息,含品牌所属公司介绍,Primera芙莉美娜所处行业的品牌地位及优势。
咨询